Fighting Allergy

Lots of people suffer from constant allergic reactions, which usually are accompanied with crucial body transformations, hair losses, serum rashes and what s ever. Therefore, it is a real challenge for modern medical industry to create universal and effective methods to struggle with allergy phenomenon. The situation is getting more severe and urgent, as far as there lots of things and items having to ability to provoke this condition. Literally, allergic people usually have one or a few things, which can threaten with allergic reaction. So, the invention of helpful medicines is really of high importance.The answer was given by Finns. In particular, Finnish scholars stated that such a medicine might be ready in 5-7 years, which cannot but delight allergy-dependent people. Antibodies of immunoglobulin E (IgE) cause human white blood cells to release histamine, which, in its turn, causes allergic responses – beginning from tears in the eyes up to skin rashes. Scientists have found a way to genetically modify allergic cells; in this context, they are not going to connect with IgE, but immunoglobulin G. IgG obstruct the allergy appearance, particularly, the formation of IgE allergic cells. This makes it possible to block the release of histamine from white blood cells, and thus block the manifestation of allergies such as runny nose and sneezing.In theory such a way of overcoming the allergy is pretty simple: all you need is the doctors to inject the modified version and let the body to do everything needed. The miraculous medicine is likely to enter the pharmaceutical market just in seven years, but the result is worth waiting. In order to enhance the production of medicines, scientists have established a firm, holding the related responsibility, - Desentum. Certainly, some attempts to get a vaccine from allergy were made before; some of them even astonished with their creativity and originality. The best example is scholars from the University of Vienna. Austrian Professor Rudolf Valenta and his colleagues at the University have developed an allergy vaccine based on genetically modified component of birch pollen. With the help of genetic modification they could significantly reduce the allergen influence in birch pollen, so that the probability to call an allergic reaction has decreased in 100 times. 124 adult individuals have tested this vaccine; secretly, some of them were injected with placebo. As a result, researchers have discovered a vaccine in action with increasing number of antibodies of immunoglobulin G (IgG), which inhibit an allergic reaction. Hence, recent decades are marked with development of anti-allergy vaccines, rather than methods for treating allergy.